Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 293-263-8 | CAS number: 91053-01-9 A complex combination of hydrocarbons obtained from distillation of the butadiene-free C4 fraction of a naphtha steam-cracking process. It consists predominantly of olefinic hydrocarbons having carbon numbers of C8, C12, C16 and C20 and boiling in the range of approximately 170°C to 185°C (338°F to 365°F).
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
In vitro
In vitro bacterial reverse mutation assays exist for butylene dimers, trimers and tetramers; studies on other higher olefins are used to cover the carbon number range C8 to C20. All of these butylene oligomers and higher olefins are not genotoxic.
No mutagenic activity was observed with isooctene (up to 5,000 ug/plate) when tested with S. typhimurium or E.coli strains in the presence or absence of metabolic activation (CAS 11071 -47 -9, HLS, 2009 a). 2,4,4-Trimethylpentene was not mutagenic to S. typhimirium or E. coli strains in the presence or absence of metabolic activation at concentrations up to 5,000 ug/plate (HLS, 1996 e). Triisobutylene (CAS 7756 -94 -7) was not mutagenic to S. typhimirium or E. coli strains in the presence or absence of metabolic activation at concentrations up to 5,000 Ig/plate (Hatano Research Institute a). Tributene (CAS 97280 -83 -6) was also not mutagenic to S. typhimurium and E. coli strains in the presence or absence of metabolic activation at up to 5,000 ug/plate (HLS, 2009 b). Neither was tetrabutene (CAS 9003 -29 -6) mutagenic to S. typhimurium or E. coli strains in the presence or absence of metabolic activation at up to 5,000 ug/plate (Harlan, 2009). C2-24 alkenes, linear and branched were also found to be non-mutagenic to bacterial strains of S. typhimurium and E.coli in the presence or absence of metabolic activation at concentrations up to 5,000 ug/plate (SafePharm, 1998 c).
2,4,4-Trimethylpentene was negative when tested in an in vitro chromosomal aberration test using human peripheral blood lymphocytes in the presence or absence of metabolic activation (HLS, 1997 d). Triisobutylene was negative when tested in an in vitro chromosomal aberration test using Chinese hamster CHL/IU cells in the presence or absence of metabolic activation (Hatano Research Institute b).
In vivo
An in vivo cytogenetics test exists for diisobutylene (butylene dimer); other studies on other higher olefins are used to cover the carbon number range C8 to C20 for this category. All of these higher olefins including diisobutylene are not genotoxic.
Diisobutylene did not significantly increase the incidence of micronucleated polychromatic erythrocytes in male or female rats exposed by inhalation to concentrations of 0, 995, 2035 or 4015 ppm for 4 hours (WIL, 2006). A single oral dose of 7.85 g/kg hexadecene (CAS 629 -73 -2) was not genotoxic in a mouse bone marrow micronucleus assay (Research Institute for Organic Synthesis, 1990). No increased micronuclei were noted in a mouse bone marrow micronucleus assay at intraperitoneal doses of 0, 500, 1000 or 2000 mg/kg C20-24 alkenes, branched and linear (SafePharm, 1998 d).
Short description of key information:
There is no evidence of mutagenicity in vitro or in vivo in a range of recognised core assay types conducted with butylene oligomers or representative olefins. In vitro studies comprise six bacterial reverse mutation assays with olefins ranging from C8 to C20/24 and two mammalian chromosome aberration tests with C8. There are also four negative in vivo mammalian erythrocyte micronucleus tests in the mouse or the rat covering three different routes of administration oral, inhalation and intraperitoneal and olefins ranging from C8 to C20/C24. The results are consistent throughout the category.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
There is no evidence of mutagenicity in a range in vitro and in vivo studies with linear and branched olefins ranging from C8 to C20/C24 and there is sufficient evidence to conclude that butylene oligomers do not warrant classification under DSD Dir 67/548/EEC or GHS/CLP.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.